Your browser doesn't support javascript.
loading
4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.
Takamatsu, Yuki; Tanaka, Yasuhito; Kohgo, Satoru; Murakami, Shuko; Singh, Kamalendra; Das, Debananda; Venzon, David J; Amano, Masayuki; Higashi-Kuwata, Nobuyo; Aoki, Manabu; Delino, Nicole S; Hayashi, Sanae; Takahashi, Satoru; Sukenaga, Yoshikazu; Haraguchi, Kazuhiro; Sarafianos, Stefan G; Maeda, Kenji; Mitsuya, Hiroaki.
Afiliação
  • Takamatsu Y; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Tanaka Y; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kohgo S; Research Institute & Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Murakami S; Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan.
  • Singh K; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Das D; Molecular Microbiology & Immunology, Biochemistry, School of Medicine and Bond Life Sciences Center, University of Missouri, Columbia, MO.
  • Venzon DJ; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Amano M; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Higashi-Kuwata N; Departments of Hematology, Rheumatology, and Clinical Immunology & Infectious Disease, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
  • Aoki M; Research Institute & Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Delino NS; Departments of Hematology, Rheumatology, and Clinical Immunology & Infectious Disease, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
  • Hayashi S; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Takahashi S; Departments of Hematology, Rheumatology, and Clinical Immunology & Infectious Disease, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
  • Sukenaga Y; Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan.
  • Haraguchi K; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Sarafianos SG; Department of Virology & Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Maeda K; Department of Experimental Pathology & Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Mitsuya H; Research Institute & Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Hepatology ; 62(4): 1024-36, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26122273
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Desoxiadenosinas Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Desoxiadenosinas Idioma: En Ano de publicação: 2015 Tipo de documento: Article